# NHS Framework Agreement for the supply of Recombinant Factor IX products for the treatment of Haemophilia B

> Pre-procurement notice from UK public-sector procurement sources.

## Key facts

- Public buyer: [NHS ENGLAND](/buyers/nhs-england/contract-awards)
- Tender value: £45,000,000
- Published: 21 October 2021
- Planned start: 1 March 2022
- Planned end: 28 February 2023
- Stage: pre_procurement
- Notice ID: 9578831c-2180-4692-84c0-b61f98b0da00-478911
- OCID: ocds-b5fd17-69ed4de5-2b39-4e5a-a757-1c3337e7211c

## Description

Recombinant Factor IX

## Related contract awards

- [Transformation Delivery Services - Establishing Operational Excellence \(EOE\)](/contracts/ocds-b5fd17-b08595d2-8961-409b-9b62-7b01d7a64541): NHS England
- [Identity Access Management - Service Adoption and Enablement](/contracts/ocds-b5fd17-08ebad6c-84fb-4e62-9afd-d06d220dd3a5): NHS England
- [OutSystems licenses for MAPPTI \(AP&P\)](/contracts/ocds-b5fd17-521fbf90-6e93-4366-b3bc-47aa2efd447d): NHS England

## Source

[View the original notice on Contracts Finder](https://www.contractsfinder.service.gov.uk/Notice/9578831c-2180-4692-84c0-b61f98b0da00-478911)